fluconazole has been researched along with Nausea in 10 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy and tolerance of fluconazole in the treatment of oesophageal candidiasis, 47 AIDS patients with this infection were enrolled in an open prospective study using fluconazole 100 mg given orally once daily." | 9.07 | Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. ( Clumeck, N; De Wit, S; Rahir, F; Urbain, D; Weerts, D, 1991) |
| "To assess the efficacy and tolerance of fluconazole in the treatment of oesophageal candidiasis, 47 AIDS patients with this infection were enrolled in an open prospective study using fluconazole 100 mg given orally once daily." | 5.07 | Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. ( Clumeck, N; De Wit, S; Rahir, F; Urbain, D; Weerts, D, 1991) |
| " Four patients presented nausea and vomiting as an AE, although aerosolized amphotericin B was ongoing." | 3.74 | Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation. ( Borro, JM; de la Torre, M; Delgado, M; Fernandez, R; Gonzalez, D; Monte, E; Pastor, A; Saura, A; Solé, A, 2008) |
| "Fluconazole, a novel triazole antifungal agent, was given orally or intravenously to 10 patients with pulmonary mycosis (7 patients with primary pulmonary cryptococcosis and 3 with pulmonary aspergillosis)." | 3.67 | [Clinical efficacy of fluconazole in the patient with pulmonary mycosis]. ( Hanawa, T; Hatakenaka, R; Ikeda, S; Katsura, A; Kosaba, S; Lee, Y; Matsubara, Y; Ninomiya, K; Shiota, T; Yagi, K, 1989) |
| " We conducted a prospective phase II dose escalation study employing doses of fluconazole ranging from 800 to 2000 mg daily for 10 weeks used alone or combined with flucytosine at 100 mg/kg per day for the first 4 weeks." | 2.73 | Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis. ( Bozzette, SA; Haubrich, R; Larsen, RA; Leal, MA; Leedom, JM; McCutchan, JA; Milefchik, E; Tilles, JG, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Puy, F | 1 |
| Kay, GN | 1 |
| Borro, JM | 1 |
| Solé, A | 1 |
| de la Torre, M | 1 |
| Pastor, A | 1 |
| Fernandez, R | 1 |
| Saura, A | 1 |
| Delgado, M | 1 |
| Monte, E | 1 |
| Gonzalez, D | 1 |
| Hamoud, S | 1 |
| Keidar, Z | 1 |
| Hayek, T | 1 |
| Kolbin, AS | 1 |
| Klimko, NN | 1 |
| Karpov, OI | 1 |
| Milefchik, E | 1 |
| Leal, MA | 1 |
| Haubrich, R | 1 |
| Bozzette, SA | 1 |
| Tilles, JG | 1 |
| Leedom, JM | 1 |
| McCutchan, JA | 1 |
| Larsen, RA | 1 |
| Nozickova, M | 1 |
| Koudelkova, V | 1 |
| Kulikova, Z | 1 |
| Malina, L | 1 |
| Urbanowski, S | 1 |
| Silny, W | 1 |
| Gupta, AK | 1 |
| Gregurek-Novak, T | 1 |
| De Wit, S | 1 |
| Urbain, D | 1 |
| Rahir, F | 1 |
| Weerts, D | 1 |
| Clumeck, N | 1 |
| Lee, Y | 1 |
| Shiota, T | 1 |
| Ikeda, S | 1 |
| Katsura, A | 1 |
| Hanawa, T | 1 |
| Yagi, K | 1 |
| Kosaba, S | 1 |
| Hatakenaka, R | 1 |
| Matsubara, Y | 1 |
| Ninomiya, K | 1 |
1 review available for fluconazole and Nausea
| Article | Year |
|---|---|
[Side effects of systemic antimycotics].
Topics: Amphotericin B; Antifungal Agents; Chills; Fever; Fluconazole; Humans; Itraconazole; Meta-Analysis a | 2003 |
4 trials available for fluconazole and Nausea
| Article | Year |
|---|---|
Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Cohort Studie | 2008 |
A comparison of the efficacy of oral fluconazole, 150 mg/week versus 50 mg/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Candida; Candidiasis; Chemical and Drug Induced Live | 1998 |
Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Follow-Up Studies; Foot Dermatoses; Gastrointestinal | 2001 |
Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Alanine Transaminase; Asparta | 1991 |
5 other studies available for fluconazole and Nausea
| Article | Year |
|---|---|
Electrocardiogram Challenge Syncope in a Woman With Nausea and Diarrhea.
Topics: Aged; Cholecalciferol; Clonazepam; Diarrhea; Esomeprazole; Female; Fluconazole; Humans; Nausea; Onda | 2017 |
Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antifunga | 2008 |
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; F | 2011 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
[Clinical efficacy of fluconazole in the patient with pulmonary mycosis].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antifungal Agents; Aspergillosis; Cr | 1989 |